510(k) device
MONARCH Platform (MON-000008)
Auris Health, Inc. · Bronchoscope (Flexible Or Rigid) (EOQ, Class II) · First FDA decision Apr 15, 2020, newest Jul 25, 2026Lung cancer and lung nodules
Last checked: Nov 21, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
510(k) pathway
Device trials
25
Naming "MONARCH"
MAUDE reports
4,160
Brand "MONARCH", since 2015
PubMed studies
1,186
Mentioning "MONARCH"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing MONARCH Platform (MON-000008)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
K260382 · Decided Jul 25, 2026 · 170 days after receipt
Device type: Bronchoscope (Flexible Or Rigid) (EOQ) · Otolaryngology (ENT)
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "MONARCH", any status and sponsor, newest update first.
Santa Casa Medical SchoolAcademic, hospital or other
NCT02562677 · 0 participants · Start Oct 2015 · Primary completion Dec 2015
Device: Transcutaneous Trigeminal Nerve Stimulation · For: Major Depressive Disorder; Elderly
24 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "MONARCH", and for the whole product code for context.
This brand
4,160 reports: 3,678 malfunction, 476 injury, 3 death
Whole product code EOQ
33,033 reports: 28,729 malfunction, 4,104 injury, 190 death
Newest reports for this brand
- MONARCH III IOL Delivery System, Cartridge DMalfunction
Alcon Research, LLC - Huntington
1119421-2026-02150 · Received Oct 29, 2026
Device type: Folders And Injectors, Intraocular Lens (Iol) (MSS)
Device problem as coded: Crack
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- MONARCH Platform, Bronchoscopy, Catalog Numbers: MON-000005-01 , MON-000005-01R , MON-000006 , MON-000006-RFB, MON-000008 with softwareOpen, Classified
Z-1383-2026 · Started Jan 21, 2026 · Posted by FDA Feb 17, 2026
Reason given: Device for bronchoscopic visualization, patient airway access has software issue: if application restarts after patient-side selection, prior to bronchoscope loading, application will re-initialize to patient-left position; and if right position was previously selected, this may lead to unanticipated robotic arm...
Cause as FDA categorized it: Software design · Device type: Bronchoscope (Flexible Or Rigid) (EOQ)
4 more recall records with a free account
Published research
The most relevant PubMed records for "MONARCH"[tiab]. The summary above synthesizes these.
- Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3.
Goetz MP, Toi M, Huober J, et al. · Ann Oncol · 2024Randomized Controlled Trial, Clinical Trial, Phase III
- Monarch plus: a research review.
Sun T, Xu J, Yang J · Transl Breast Cancer Res · 2022Editorial, Comment
- Demystifying Monarch Butterfly Migration.
Reppert SM, de Roode JC · Curr Biol · 2018Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.
- Neurobiology of Monarch Butterfly Migration.
Reppert SM, Guerra PA, Merlin C · Annu Rev Entomol · 2016Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Drugs for ADHD.
Med Lett Drugs Ther · 2020Review
- [ࡲ. MONARCH-E and Oncotype DX].
Kashiwagi S · Gan To Kagaku Ryoho · 2024
- The Monarch Bear.
Volski L · Science · 2026
- The neurobiology of the Monarch butterfly compass.
Beetz MJ, El Jundi B · Curr Opin Insect Sci · 2023Review, Research Support, Non-U.S. Gov't
- Monarch butterfly conservation through male germplasm cryopreservation.
Grula CC, Rajamohan A, Rinehart JP · Sci Rep · 2024
- Stimulus-dependent orientation strategies in monarch butterflies.
Franzke M, Kraus C, Gayler M, et al. · J Exp Biol · 2022Research Support, Non-U.S. Gov't
- Bogong moths.
Heinze S, Warrant E · Curr Biol · 2016
- Monarch butterflies memorize the spatial location of a food source.
Konnerth MM, Foster JJ, El Jundi B, et al. · Proc Biol Sci · 2023Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code EOQ.
- Ion Endoluminal System (IF1000)Intuitive Surgical, Inc. · 510(k) 2025
- Ambu® aScope 5 Broncho 2.7/1.2Ambu A/S · 510(k) 2026
- Evis Exera III Bronchovideoscope (Olympus BF-Q190)Olympus Medical Systems Corp. · 510(k) 2026
- Vathin® Video Bronchoscope SystemHunan Vathin Medical Instrument Co., Ltd. · 510(k) 2025
- FUJIFILM Endoscope Model EB-840SFujifilm Corporation · 510(k) 2026
- Broncho Videoscope System (Single-use Broncho Videoscope (SBV-1A-BScivita Medical Technology Co., Ltd. · 510(k) 2025
- Single-use Flexible BronchoscopeHunan Vathin Medical Instrument Co., Ltd. · 510(k) 2026
- LoopView® Single-Use Digital Flexible Bronchoscope (B27-C, B27-CG)MacroLux Medical Technology Co., Ltd. · 510(k) 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.